The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Small Molecule Drug Discovery Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The small molecule drug discovery market has seen rapid expansion over recent years. Its valuation is projected to rise from $67.94 billion in 2025 to $75.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.2%. The historical expansion of this market is primarily due to increased research and development investments by pharmaceutical companies, a rise in the prevalence of chronic diseases, progress in molecular biology techniques, an increasing need for economical therapeutics, and the appearance of contract research organizations (CROs).
The small molecule drug discovery market is projected to experience significant expansion over the coming years, reaching a valuation of $117.05 billion by 2030. This growth is anticipated to occur at a compound annual growth rate (CAGR) of 11.6%. Several factors are expected to fuel this progress during the forecast period, including the incorporation of AI and machine learning into drug discovery processes, the expansion of initiatives in precision medicine, increased collaboration between biotechnology and pharmaceutical companies, the implementation of automated high-throughput platforms, and a heightened focus on addressing rare and complex diseases. Key developments expected within this period include the widespread embrace of high-throughput screening, advancements in combinatorial chemistry, the integration of nanotechnology into drug design, the evolution of personalized medicine, and improvements in target validation and lead optimization strategies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp
Which Growth Drivers Are Expected To Support The Small Molecule Drug Discovery Market Forward?
The prevalence of chronic illnesses is anticipated to stimulate expansion within the small molecule drug discovery market in the future. These conditions are defined as ailments persisting for a year or more, impeding daily functions, requiring ongoing medical attention, or a combination of these factors. Small-molecule drugs offer therapeutic options for chronic ailments such as HIV, cancer, various infections, heart conditions, and renal diseases, frequently offering a more cost-effective solution for those afflicted. Consequently, the increasing occurrence of chronic diseases is projected to drive growth in the small molecule drug discovery market. For example, a 2023 report from the National Institutes of Health (NIH), a US biomedical research body, indicates that by 2050, the population in the United States aged 50 and above suffering from at least one chronic illness is predicted to hit 142.66 million. Furthermore, individuals experiencing multiple chronic conditions (multimorbidity) are forecast to rise to 14.968 million by the same year. Thus, the increasing prevalence of chronic diseases is serving as a primary catalyst for the expansion of the small molecule drug discovery market.
What Are The Core Segment Classifications In The Small Molecule Drug Discovery Market?
The small molecule drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others
Subsegments:
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies
Which Trends Are Influencing The Direction Of The Small Molecule Drug Discovery Market?
Key companies engaged in small molecule drug discovery are initiating collaborations to enhance their market revenues. Such partnerships frequently promote innovation through the integration of diverse entities’ expertise. For example, in November 2023, Evommune, a US-based non-profit organization, and Accutar Biotechnology, a US-based biotechnology company, revealed a strategic partnership concentrating on AI-powered drug discovery, particularly for chronic inflammatory diseases. This cooperative venture aims to capitalize on Accutar’s specialized AI platform and Evommune’s knowledge to identify novel small molecule drug candidates.
Which Organizations Are Involved In The Small Molecule Drug Discovery Market?
Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences
Access The Complete Small Molecule Drug Discovery Market Report:
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
Which Region Is The Dominant Market In The Small Molecule Drug Discovery Market?
North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Small Molecule Drug Discovery Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp
Browse Through More Reports Similar to the Global Small Molecule Drug Discovery Market 2026, By The Business Research Company
Small Molecule Drug Discovery Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
Small Molecule Active Pharmaceutical Ingredient Market Report 2026
Rna Targeting Small Molecule Drug Discovery Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model